natgillin/translations-raw huggingface dataset:
(25) Raziskovalne dejavnosti, ki jih podpira ta okvirni program, spoštujejo temeljna etična načela, vključno s tistimi iz Listine Evropske unije o temeljnih človekovih pravicah , varstvo človekovega dostojanstva in življenja, varstvo osebnih podatkov in zasebnosti in varstvo okolja v skladu s pravom Skupnosti, zadevnimi mednarodnimi pogodbami in najnovejšo različico Helsinške deklaracije, Konvencijo Sveta Evrope o človekovih pravicah in biomedicini, podpisano v Oviedu 4. aprila 1997, in njenim dodatnim protokolom o prepovedi kloniranja človeka, podpisanim v Parizu 12. januarja 1998, Konvencijo ZN o otrokovih pravicah, Splošno deklaracijo o človeškem genomu in človekovih pravicah, ki jo je sprejel Unesco, resolucijo Generalne skupščine Združenih narodov z dne 8. marca 2005 (A/RES/59/280), ustreznimi resolucijami Svetovne zdravstvene organizacije (WHO), resolucijama Evropskega parlamenta z dne 10. marca 2005 o trgovini s človeškimi jajčnimi celicami 1 in z dne 26. oktobra 2005 o patentiranju biotehnoloških izumov 2 , ter z zakoni in predpisi, ki veljajo v državah, kjer potekajo zadevni raziskovalni projekti.
(25) Research activities supported by this Framework Programme should respect fundamental ethical principles, including those reflected in the Charter of Fundamental Rights of the European Union , the protection of human dignity and human life, the protection of personal data and privacy and the protection of the environment in compliance with Community law, the relevant international treaties and the Helsinki Declaration in its most recent version, the Council of Europe’s Convention on Human Rights and Biomedicine, signed in Oviedo on 4 April 1997, and the Additional Protocol thereto on the prohibition of cloning human beings, signed in Paris on 12 January 1998, the UN Convention on the Rights of the Child, the UNESCO Universal Declaration on the Human Genome and Human Rights, the United Nations General Assembly resolution of 8 March 2005 (A/RES/59/280), the relevant resolutions of the World Health Organization (WHO), the European Parliament’s resolutions of 10 March 2005 on the trade in human egg cells 1 and of 26 October 2005 on patents for biotechnological inventions 2 and the laws and regulations valid in the countries where the research projects in question are conducted.
1 UL C 320 E, 15.12.2005, str.
1 OJ C 320 E, 15.12.2005, p.
2 Sprejeta besedila, P6_TA(2005)0407 .
2 Texts Adopted, P6_TA(2005)0407 .
Uvodna izjava 25 c (novo)
Recital 25 c (new)
(25c) Posredovanja Skupnosti na podlagi njenih dopolnilnih pristojnosti je treba omejiti na dopolnjevanje, podporo ali usklajevanje dejavnosti držav članic.
(25c) Intervention by the Community on the basis of its complementary competencies should be limited to supplementing, supporting or coordinating the action of the Member States.
Na teh področjih je pogosta negativna opredelitev pristojnosti (npr. izločitev usklajevanja na določenih področjih).
In such areas negative delimitation of competence (e.g. the exclusion of harmonisation in certain areas) is common.
Skupnost lahko s svojimi dejavnostmi le spodbuja sodelovanje med državami članicami in, kjer je to potrebno, podpira in dopolnjuje njihove dejavnosti.
The Community may only act to encourage cooperation between the Member States and, where necessary, to support and supplement their actions.
Pristojnost sprejemanja zakonodajnih predpisov na teh področjih ostaja v rokah držav članic, zato morajo posredovanja Skupnosti dopustiti tudi posredovanja držav članic.
The power to adopt legislative rules in these areas remains in the hands of the Member States, and intervention by the Community should not have the effect of excluding intervention by the Member States.
Člen 2, točka (5)
Article 2, point (5)
(5) Zmogljivosti: podpora ključnim vidikom evropskih raziskovalnih in inovacijskih zmogljivosti, kot so raziskovalne infrastrukture; regionalne, v raziskave usmerjene skupine; razvoj celotnega raziskovalnega potencialna v konvergenčnih in najbolj oddaljenih regijah Skupnosti; raziskave v korist malim in srednje velikim podjetjem (MSP); vprašanja na področju „znanosti v družbi“; horizontalne dejavnosti mednarodnega sodelovanja.
(5) Capacities: supporting key aspects of European research and innovation capacities such as research infrastructures; regional research driven clusters; the development of a full research potential in the Community’s convergence and outermost regions; research for the benefit of small and medium sized enterprises (SMEs); “Science in Society” issues; horizontal activities of international cooperation.
(5) Zmogljivosti: podpora ključnim vidikom evropskih raziskovalnih in inovacijskih zmogljivosti, kot so raziskovalne infrastrukture; regionalne, v raziskave usmerjene skupine; razvoj celotnega raziskovalnega potencialna v konvergenčnih in najbolj oddaljenih regijah Skupnosti; raziskave v korist malim in srednje velikim podjetjem (MSP); vprašanja na področju „znanosti v družbi“ , vključno z etičnimi vprašanji ; horizontalne dejavnosti mednarodnega sodelovanja.
(5) Capacities: supporting key aspects of European research and innovation capacities such as research infrastructures; regional research driven clusters; the development of a full research potential in the Community’s convergence and outermost regions; research for the benefit of small and medium sized enterprises (SMEs); “Science in Society” issues including ethical issues ; horizontal activities of international cooperation.
Etični vidiki in kritična razmišljanja o raziskavah imajo v osnutku Komisije manjšo vlogo, kot pa so jo imeli v zdajšnjem in prejšnjem okvirnem programu.
Compared to the existing framework program and the former once, the Commission draft gives less priority to ethical aspects and critical reflection of research.
Parlament mora to spremeniti.
This needs to be changed by Parliament.
Vse raziskovalne dejavnosti iz sedmega okvirnega programa se izvajajo v skladu s temeljnimi etičnimi načeli .
All the research activities carried out under the seventh Framework Programme shall be carried out in compliance with fundamental ethical principles.
Vse raziskovalne dejavnosti iz sedmega okvirnega programa se izvajajo ob spoštovanju osebne nedotakljivosti, načela enakopravnosti moških in žensk ter temeljnih etičnih načel .
All the research activities carried out under the seventh Framework Programme shall be carried out with respect for the integrity of the person, the principle of equality between men and women and fundamental ethical principles.
Naslednje raziskovalne dejavnosti se ne financirajo s sedmim okvirnim programom:
The following shall not be financed under the seventh Framework Programme:
- raziskovalni projekti, ki so v državah članicah prepovedani zaradi razlogov, ki temeljijo na osnovnih idejah o človekovih pravicah in na ustavnih načelih;
- research projects which are prohibited in Member States for reasons based on primary human rights considerations and constitutional principles;
- raziskovalni projekti, ki ogrožajo osnovne vrednote človekovega dostojanstva;
- research projects which endanger primary values of human dignity;
- raziskovalne dejavnosti s ciljem kloniranja človeških zarodkov;
- research activities aimed at the cloning of human embryos;
- raziskovalne dejavnosti, katerih namen je spreminjanje genske dediščine ljudi in zaradi katerih bi takšne spremembe lahko postale dedne;
- research activities intended to modify the genetic heritage of human beings which could make such changes hereditary;
- posegi v človeško zarodno linijo;
- interventions in the human germ line;
- uporaba in ustvarjanje zarodkov in zarodkovih izvornih celic za uporabo v znanstvenih raziskavah, ker so ljudje sami sebi namen, človeškega telesa, zlasti ženskega, pa se ne bi smelo izrabljati v komercialne namene.
- the use and the creation of embryos and embryonic stem cells for purposes of scientific research, since human beings are ends in themselves and the human body, in particular the female body, should not be commercialised.
Raziskave himer se ne financirajo niti neposredno niti posredno.
No direct or indirect funding shall be provided for research on chimeras.
Ta predlog spremembe temelji na besedilu Komisije, namenjenem posebnim programom, ki pa je bilo spremenjeno v skladu s sklepom EP iz marca 2005 in z enim od starejših mnenj odbora JURI.
The amendment is based on the wording of the Commission for the specific programmes, but is modified with view on the decision of the EP from March 2005, as well as on an earlier opinion of the JURI committee.
Zelo stroga interpretacija načela subsidiarnosti je kot posledica afere Hwang v Južni Koreji bolj pomembna kot kdajkoli prej.
As a consequence of the Hwang affair in South Korea, it is even more important than ever to interpret the subsidiarity principle in a very strict manner.
V primerih, kjer je določena tehnologija etično sporna (npr. raziskave z zarodkovimi izvornimi celicami, odvečni zarodki od oploditev zunaj telesa, vprašanja o uporabi genskih podatkov, kjer ni potrebe po zdravljenju), Skupnost da prednost raziskovalnim projektom, ki predstavljajo alternativo omenjenim etično spornim tehnologijam (npr. raziskave z izvornimi celicami odraslih in izvornimi celicami iz popkovine, zdravljenje plodnostnih motenj brez ustvarjanja odvečnih zarodkov, gensko testiranje v povezavi z zdravljenjem).
In cases where a technology is controversial from an ethical point of view (e.g. research involving embryonic stem cells, supernumerary embryos from IVF, questions arising as to the use of genetic data where no therapies exist), the Community shall give priority to research projects presenting an alternative to those ethically controversial technologies (e.g. research involving adult stem cells and stem cells from the umbilical cord, treatment of fertility disorders without the creation of supernumerary embryos, genetic testing in connection with therapy);
Čeprav morda obstajajo različna mnenja glede tega, ali naj EU podpira sporne tehnologije, bi morali soglasno preseči etično dilemo s podpiranjem in dajanjem prednosti etično nespornim tehnologijam.
While there are maybe different opinions on the question, if controversial technologies should be supported by the EU, it should be consensus overcoming the ethical dilemma by supporting and prioritising the ethically not disputed technologies.
Komisija najpozneje do leta 2010 s sodelovalnim procesom, ki vključuje zunanje strokovnjake in civilno družbo, pripravi vmesno oceno tega okvirnega programa in njegovih posebnih programov glede kakovosti raziskovalnih dejavnosti, ki so v teku, in napredka v smeri zastavljenih ciljev.
Not later than 2010, the Commission shall carry out, by means of a participatory process involving external experts and civil society , an interim evaluation of this Framework Programme and its specific programmes on the quality of the research activities under way and progress towards the objectives set.
Civilna družba bi morala sodelovati v procesu ocenjevanja zavoljo zagotavljanja preglednosti in demokratičnosti v odločitvah glede sredstev EU, namenjenih raziskavam.
Civil society should participate in the process of evaluation to ensure transparency and democracy in the decisions concerning the EU-research funds.
Priloga I, Del I “Sodelovanje”, odstavek 10
Annex I, Part I “Cooperation”, paragraph 10
Etična načela , vključno s tistimi, ki so izražena v Listini Evropske unije o temeljnih človekovih pravicah in v Konvenciji Sveta Evrope o človekovih pravicah in biomedicini, in vidik enakopravnosti med spoloma se bodo upoštevali.
Ethical principles , including those reflected in the Charter of Fundamental Rights of the European Union and the Council of Europe Convention on Human Rights and Biomedicine, and gender aspects will be taken into account.
Priloga I, Del I “Sodelovanje”, naslov 2 “Skupne tehnološke pobude”, odstavek 2, alinea 1 a (novo)
Annex I, Part I “Cooperation”, heading 2 “Joint Technology Initiatives”, paragraph 2, indent 1 a (new)
- Pomen civilne družbe:
- Civil society relevance.
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 1 “Zdravje”, podnaslov 2 “Utemeljitev”, odstavek 3
Annex I, Part I “Cooperation”, Section “Themes”, point 1 “Health”, subpoint 2 “Rationale”, paragraph 3
Posamezniki so sami sebi namen in se ne izrabljajo kot sredstva.
Individuals are an end in themselves and will not be used as a means.
Nadalje je treba poudariti, da bodo raziskave EU sledile previdnostnemu načelu s stalnimi presojami morebitnih tveganj, ki bi jih lahko predstavljali ne popolnoma predvidljivi vplivi novih tehnologij.
It is further stressed that EU research will follow the precautionary principle by continuously assessing possible risks attaching to the not fully foreseeable impact of new technologies.
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 1 “Zdravje”, podnaslov 3 “Dejavnosti”, podnaslov 1 “Biotehnologija, generična orodja in tehnologije za človekovo zdravje”, alinea 2
Annex I, Part I “Cooperation”, Section “Themes”, point 1 “Health”, subpoint 3 “Activities”, subheading 1 “Biotechnology, generic tools and technologies for human health”, indent 2
– Odkrivanje, diagnoza in spremljanje.
– Detection, diagnosis and monitoring.
Prednost bi morala imeti diagnostična orodja, ki so neposredno povezana z zdravljenjem.
Priority should be given to diagnostic tools that are directly linked to therapy.
Diagnostika je v zadnjih letih skokovito napredovala, zlasti na področju genetskih bolezni, pa tudi drugje, še posebej zaradi dekodiranja zapisa DNK.
In genetic diseases in particular but also in other diseases, diagnostic has made tremendous progress during the last years, especially because of sequencing of DNA.
Med diagnozo in zdravljenjem pa je velika razlika.
There’s a big gap between diagnosis and therapy.
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 1 “Zdravje”, podtočka 3 “Dejavnosti”, podnaslov 2 “Translacijske raziskave, ki služijo človekovemu zdravju”, alinea 4 a (novo)
Annex I, Part I “Cooperation”, Section “Themes”, point 1 “Health”, subpoint 3 “Activities”, subheading 2 “Translating research for human health”, indent 4 a (new)
Mnogo bolezni še ne bo ozdravljivih v naslednjih sedmih do osmih letih.
Many diseases will not be curable in the next seven to eight years.
Tudi po preteku sedmega okvirnega raziskovalnega programa bodo ljudje umirali zaradi bolezni.
Also after expiration of RFP7, humans will die of diseases.
Cilj paliativne medicine je lajšanje trpljenja, predvsem bolečin, pa tudi drugih simptomov kot so žeja, srbenje in slabost, ko se proti bolezni sami ni več mogoče bojevati.
The aim of palliative medicine is to fight suffering, mainly pain but also other symptoms like thirst, itching and nausea when the disease itself cannot be fought causally anymore.
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 1 “Zdravje”, podnaslov 3 “Dejavnosti”, podnaslov 3 “Optimalizacija zdravstvenega varstva evropskih državljanov”, alinea 2
Annex I, Part I “Cooperation”, Section “Themes”, point 1 “Health”, subpoint 3 “Activities”, subheading 3 “Optimising the delivery of health care to European citizens”, indent 2
Dostop do zdravstvenega varstva za zapostavljene skupine, vključno z invalidnimi osebami.
Access to health care for disadvantaged groups including disabled persons.
Treba je raziskati, kako zdravstveno varstvo seže do zapostavljenih skupin.
Research in respect of how health care reaches disadvantaged groups needs to be investigated.
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 2 “Prehrana, kmetijstvo in biotehnologija”, podnaslov 3 “Dejavnosti”, odstavek 1
Annex I, Part I “Cooperation”, Section “Themes”, point 2 “Food, Agriculture and Biotechnology”, subpoint 3 “Activities”, paragraph 1
• Trajnostna proizvodnja in gospodarjenje z biološkimi viri iz tal, gozdov in vodnih okolij: Omogočanje raziskav na področjih, vključno s tehnologijami, katerih poimenovanja se končajo na „-omika“, kot so genomika, proteomika, metabolomika, sistemska biologija in konvergenčne tehnologije za mikroorganizme, rastline in živali, vključno z izkoriščanjem njihove biološke raznovrstnosti; izboljšani pridelki in proizvodni sistemi, vključno z ekološkim kmetijstvom, kakovostnimi načrti pridelave in učinki GSO; trajnostno, konkurenčno in večnamensko kmetijstvo in gozdarstvo; razvoj podeželja; dobro počutje živali, reja in proizvodnja; zdravje rastlin; trajnostno in konkurenčno ribištvo in ribogojstvo; nalezljive bolezni pri živalih, vključno z zoonozami; varno odlaganje živalskih odpadkov; ohranjanje, upravljanje in izkoriščanje živih vodnih virov, razvijanje orodij, ki jih potrebujejo načrtovalci politike in drugi akterji na področju kmetijstva in razvoja podeželja (krajina, prakse ravnanja z zemljišči itd.).
• Sustainable production and management of biological resources from land, forest, and aquatic environments: Enabling research, including ‘omics’ technologies, such as genomics, proteomics, metabolomics, systems biology and converging technologies for micro-organisms, plants and animals, including exploitation of their biodiversity; improved crops and production systems, including organic farming, quality production schemes and GMO impacts; sustainable, competitive and multifunctional agriculture, and forestry; rural development; animal welfare, breeding and production; plant health; sustainable and competitive fisheries and aquaculture; infectious diseases in animals, including zoonoses; safe disposal of animal waste; conservation, management and exploitation of living aquatic resources, developing the tools needed by policy makers and other actors in agriculture and rural development (landscape, land management practices etc.).
• Trajnostna proizvodnja in gospodarjenje z biološkimi viri iz tal, gozdov in vodnih okolij: Omogočanje raziskav na področjih, vključno s tehnologijami, katerih poimenovanja se končajo na „-omika“, kot so genomika, proteomika, metabolomika, sistemska biologija in konvergenčne tehnologije za mikroorganizme, rastline in živali, vključno z ohranitvijo in trajnostno rabo njihove biološke raznovrstnosti in genskih virov na kmetijah in na terenu ; izboljšani pridelki in proizvodni sistemi, vključno z ekološkim kmetijstvom in drugimi trajnostnimi kmetijskimi sistemi z nizko porabo energije , kakovostnimi načrti pridelave in učinki GSO; trajnostno, konkurenčno in večnamensko kmetijstvo in gozdarstvo; celosten razvoj podeželja, vključno z vidiki sodelovanja civilne družbe pri načrtovanju in odločanju ; dobro počutje živali, reja in proizvodnja; zdravje rastlin; trajnostno in konkurenčno ribištvo in ribogojstvo; nalezljive bolezni pri živalih, vključno z zoonozami; druge grožnje zanesljivosti oskrbe s hrano in trajnosti proizvodnje hrane (vključno s spremembami podnebja in pomanjkanjem nafte); varno odlaganje , nadgradnja in uporaba živalskih odpadkov; ohranjanje, upravljanje in izkoriščanje živih vodnih virov, razvijanje orodij, ki jih potrebujejo načrtovalci politike in drugi akterji na področju kmetijstva in razvoja podeželja (krajina, prakse ravnanja z zemljišči itd.).
• Sustainable production and management of biological resources from land, forest, and aquatic environments: Enabling research, including ‘omics’ technologies, such as genomics, proteomics, metabolomics, systems biology and converging technologies for micro-organisms, plants and animals, including conservation and sustainable use of their biodiversity and genetic resources on farms and in situ ; improved crops and production systems, including organic and other sustainable low energy input farming systems , quality production schemes and GMO impacts; sustainable, competitive and multifunctional agriculture, and forestry; integrated rural development , including the aspects of civil society participation in planning and decision-making ; animal welfare, breeding and production; plant health; sustainable and competitive fisheries and aquaculture; infectious diseases in animals, including zoonoses; other threats to the sustainability and food supply security of food production (including climate change and oil depletion); safe disposal , upgrading and utilisation of animal waste; conservation, management and exploitation of living aquatic resources, developing the tools needed by policy makers and other actors in agriculture and rural development (landscape, land management practices etc.).
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 2 “Prehrana, kmetijstvo in biotehnologija”, podnaslov 3 “Dejavnosti”, odstavek 2
Annex I, Part I “Cooperation”, Section “Themes”, point 2 “Food, Agriculture and Biotechnology”, subpoint 3 “Activities”, paragraph 2
•„Od vil do vilic“: prehrana, zdravje in dobro počutje: Vidiki potrošnikov, družbe, industrije in zdravja glede hrane in krme, vključno z vedenjskimi in kognitivnimi znanostmi; prehranjevanje, s prehrano povezane bolezni in motnje, vključno z debelostjo; inovativne tehnologije za predelavo hrane in krme (vključno s pakiranjem); izboljšana kakovost in varnost, tako kemijska kot mikrobiološka , hrane, pijače in krme; celovitost (in nadzor) prehranske verige; vpliv okolja na prehransko verigo ljudi/živali in vpliv prehranske verige ljudi/živali na okolje; koncept celotne prehranske verige (vključno z morskimi sadeži); sledljivost.
• “Fork to farm”: Food, health and well being: Consumer, societal, industrial and health aspects of food and feed, including behavioural and cognitive sciences; nutrition, diet related diseases and disorders, including obesity; innovative food and feed processing technologies (including packaging); improved quality and safety, both chemical and microbiological , of food, beverage and feed; integrity (and control) of the food chain; environmental impacts on and of food/feed chains; total food chain concept (including seafood); traceability.
•„Od vil do vilic“: prehrana, zdravje in dobro počutje: Vidiki potrošnikov, družbe, kulture, industrije in zdravja glede hrane in krme, vključno z vedenjskimi in kognitivnimi znanostmi; prehranjevanje, s prehrano povezane bolezni in motnje, vključno z debelostjo in alergijami ; zdravstvene koristi nekaterih živil in prehrane; inovativne tehnologije za predelavo , prevoz in prodajo hrane in krme (vključno z lažjim pakiranjem in manjšo razdaljo od mesta pridobivanja hrane do mesta prodaje ); izboljšana kakovost in varnost, tako kemijska kot biološka , hrane, pijače in krme; celovitost in trajnost (in nadzor) prehranske verige; vpliv okolja na prehransko verigo ljudi/živali in vpliv prehranske verige ljudi/živali na okolje; koncept celotne prehranske verige (vključno z morskimi sadeži); sledljivost.
• “Fork to farm”: Food, health and well being: Consumer, societal, cultural , industrial and health aspects of food and feed, including behavioural and cognitive sciences; nutrition, diet related diseases and disorders, including obesity and allergies; health benefits of certain foods and diets ; innovative food and feed processing , transport and retailing technologies (including reduction of packaging and food miles ); improved quality and safety, both chemical and biological , of food, beverage and feed; integrity and sustainability (and control) of the food chain; environmental impacts on and of food/feed chains; total food chain concept (including seafood); traceability.
Priloga I, Del I “Sodelovanje”, Oddelek “Teme”, točka 8 “Socialno-ekonomske in humanistične vede”, podnaslov “Dejavnosti”, točka 4 “Evropa v svetu”
Annex I, Part I “Cooperation”, Section “Themes”, point 8 “Socio-economic sciences and humanities”, title “Activities”, indent 4 “Europe in the world”
• Evropa v svetu: razumevanje spreminjanja interakcij in soodvisnosti med regijami v svetu in njihove posledice za zadevne regije, zlasti Evropo; in obravnavanje nastajajočih groženj in tveganj brez spodkopavanja človekovih pravic, svobode in dobrobiti ljudi.
• Europe in the world: understanding changing interactions and interdependencies between world regions and their implications for the regions concerned, especially Europe; and addressing emerging threats and risks without undermining human rights, freedom and well-being.